Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis.

Systemic sclerosis hospitalization nailfold videocapillaroscopy organ involvement outcome pulmonary fibrosis

Journal

Mediterranean journal of rheumatology
ISSN: 2529-198X
Titre abrégé: Mediterr J Rheumatol
Pays: Greece
ID NLM: 101730166

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 26 11 2018
revised: 28 02 2019
accepted: 05 02 2019
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2020
Statut: epublish

Résumé

Systemic Sclerosis (SSc) is a rare, multisystemic connective tissue disease associated with significant morbidity. Early recognition of patients at risk for adverse prognosis may help towards optimized monitoring and treatment, thus improving disease outcome. To correlate nailfold videocapillaroscopy (NVC) findings ('early', 'active', 'late' scleroderma patterns and non-specific capillary abnormalities) with major organ involvement and prognosis in patients with systemic sclerosis (SSc). Patients from the Scleroderma cohort followed at the Rheumatology clinic of the University Hospital of Heraklion will be included. The study will include a prospective and a retrospective part.

Sections du résumé

BACKGROUND BACKGROUND
Systemic Sclerosis (SSc) is a rare, multisystemic connective tissue disease associated with significant morbidity. Early recognition of patients at risk for adverse prognosis may help towards optimized monitoring and treatment, thus improving disease outcome.
OBJECTIVE OBJECTIVE
To correlate nailfold videocapillaroscopy (NVC) findings ('early', 'active', 'late' scleroderma patterns and non-specific capillary abnormalities) with major organ involvement and prognosis in patients with systemic sclerosis (SSc).
METHODS METHODS
Patients from the Scleroderma cohort followed at the Rheumatology clinic of the University Hospital of Heraklion will be included. The study will include a prospective and a retrospective part.

Identifiants

pubmed: 32185343
doi: 10.31138/mjr.30.1.48
pii: MJR-30-1-48
pmc: PMC7045911
doi:

Types de publication

Journal Article

Langues

eng

Pagination

48-50

Informations de copyright

© 2019 The Mediterranean Journal of Rheumatology (MJR).

Références

Ann Rheum Dis. 2012 Oct;71(10):1636-9
pubmed: 22402146
Microvasc Res. 2013 Sep;89:122-8
pubmed: 23792167
Autoimmun Rev. 2017 Aug;16(8):787-795
pubmed: 28576600
Semin Arthritis Rheum. 2017 Aug;47(1):86-94
pubmed: 28291582
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Semin Arthritis Rheum. 2018 Dec;48(3):482-494
pubmed: 29602558
Nat Rev Rheumatol. 2010 Oct;6(10):578-87
pubmed: 20703220

Auteurs

Argyro Repa (A)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

Nestor Avgoustidis (N)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

Nikos Kougkas (N)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

George Bertsias (G)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

Michalis Zafiriou (M)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

Prodromos Sidiropoulos (P)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.

Classifications MeSH